comScore Announces Official Worldwide Box Office Results for Weekend of June 24, 2018
comScore Announces Official Worldwide Box Office Results for Weekend of June 24, 2018 -- comScore is the Trusted Industry Partner of Film Exhibitors and Distributors Across the Globe -- |
| [24-June-2018] |
LOS ANGELES, June 24, 2018 /PRNewswire/ -- comScore today announced the official worldwide weekend box office estimates for the weekend of June 24, 2018, as compiled by the company's theatrical measurement services.
As the trusted industry partner for real-time box office reporting, comScore is the only theater-level movie measurement and analytics company providing insights across the world's largest markets, covering 95 percent of the global industry gross. Using comScore's suite of movie products, customers are able to analyze admissions and gross results from around the world. comScore's Senior Media Analyst Paul Dergarabedian commented, "Some 25 years after the original 'Jurassic Park' thrilled summer movie audiences, Universal Pictures' 'Jurassic World: Fallen Kingdom' opened number one at the North American box office with $150 million while topping the international box office for the third weekend in a row with $106.7 million, including a second weekend atop the China box office where it crossed $200 million. 'Fallen Kingdom' has now grossed an estimated $561.5 million internationally, bringing the worldwide total to $711.5 million and counting and has pushed the franchise past the $4.4 billion mark." The top 12 worldwide weekend box office estimates, listed in descending order, per data collected as of Sunday, June 24, are below.
The top 12 domestic weekend box office estimates, listed in descending order, per data collected as of Sunday, June 24, are below.
Full details regarding the global domestic and international box office results are listed in the table below.
© 2018 comScore - Content in this chart is produced and/or compiled by comScore and its Box Office Essentials and International Box Office Essentials data collection and analytical services, and is covered by provisions of the Copyright Act. The material presented herein is intended to be available for public use. You may reproduce the content of the chart in any format or medium without first obtaining permission, subject to the following requirements: (1) the material must be reproduced accurately and not in a misleading manner; (2) any publication or issuance of any part of the material to others must acknowledge comScore as the source of the material; and (3) you may not receive any monetary consideration for reproducing, displaying, disclosing or otherwise using any part of the material. About comScore
SOURCE comScore | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Codes: NASDAQ-NMS:SCOR | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View original content with multimedia:© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
